CAC
JNJ icon

Core Alternative Capital’s Johnson & Johnson JNJ Stock Holding History

Core Alternative Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.61M Sell
39,298
-1,712
-4% -$399K 2.84% 6
2025
Q4 		$8.49M Buy
41,010
+716
+2% +$142K 2.34% 8
2025
Q3 		$7.47M Sell
40,294
-5,147
-11% -$882K 2.17% 8
2025
Q2 		$6.94M Sell
45,441
-3,522
-7% -$541K 1.9% 12
2025
Q1 		$8.12M Sell
48,963
-8,773
-15% -$1.37M 1.95% 13
2024
Q4 		$8.35M Sell
57,736
-2,435
-4% -$377K 1.75% 15
2024
Q3 		$9.75M Sell
60,171
-6,042
-9% -$963K 1.89% 11
2024
Q2 		$9.68M Sell
66,213
-8,414
-11% -$1.25M 1.93% 9
2024
Q1 		$11.8M Sell
74,627
-10,357
-12% -$1.65M 2.12% 9
2023
Q4 		$13.3M Sell
84,984
-20,275
-19% -$3.11M 2.28% 7
2023
Q3 		$16.4M Sell
105,259
-4,951
-4% -$817K 2.53% 6
2023
Q2 		$18.2M Sell
110,210
-12,497
-10% -$2.02M 2.67% 4
2023
Q1 		$19M Sell
122,707
-375
-0.3% -$60.6K 2.54% 6
2022
Q4 		$21.7M Buy
123,082
+23,030
+23% +$3.98M 2.77% 8
2022
Q3 		$16.3M Buy
100,052
+40,594
+68% +$6.87M 2.61% 5
2022
Q2 		$10.6M Buy
59,458
+10,096
+20% +$1.8M 2.49% 5
2022
Q1 		$8.75M Sell
49,362
-8,688
-15% -$1.48M 2.34% 8
2021
Q4 		$9.59M Buy
58,050
+633
+1% +$104K 1.93% 15
2021
Q3 		$9.27M Buy
57,417
+6,848
+14% +$1.17M 1.95% 18
2021
Q2 		$8.33M Buy
50,569
+8,755
+21% +$1.45M 1.94% 17
2021
Q1 		$6.87M Buy
41,814
+2,231
+6% +$361K 1.95% 15
2020
Q4 		$6.23M Buy
39,583
+2,805
+8% +$414K 1.87% 14
2020
Q3 		$5.48M Sell
36,778
-3,368
-8% -$498K 1.86% 22
2020
Q2 		$5.65M Sell
40,146
-4,266
-10% -$622K 1.76% 28
2020
Q1 		$5.82M Buy
44,412
+28,807
+185% +$4.09M 2.04% 9
2019
Q4 		$2.28M Buy
+15,605
New +$2.12M 2.09% 31

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Core Alternative Capital's JNJ Position: Q1 2026 in Review

Core Alternative Capital reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q1 2026, selling an estimated $399K and leaving 39,298 shares worth $9.61M. The position accounts for 2.84% of the portfolio, ranked #6.

Core Alternative Capital first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $21.7M in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Core Alternative Capital held 39,298 shares of Johnson & Johnson worth $9.61M as of Q1 2026.
  • Core Alternative Capital sold 1,712 Johnson & Johnson shares in Q1 2026, an estimated $399K.
  • Johnson & Johnson made up 2.84% of Core Alternative Capital's portfolio in Q1 2026, its #6 holding.
  • Core Alternative Capital first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Core Alternative Capital's Johnson & Johnson position peaked at $21.7M in Q4 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Core Alternative Capital's 13F filing for Q1 2026, filed 30 Apr 2026.